• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Absolute Recommendations for Imaging Taken More Seriously


Absolute recommendations for imaging, rather than conditional recommendations, result in more patients receiving the exams.

Patients are more likely to be sent for radiologist-recommended exams if they are absolute recommendations, rather than conditional ones, according to a study published in the Journal of the American College of Radiology.

Researchers from Harvard Medical School, Boston, and Lahey Hospital and Medical Center, Burlington, MA, performed a retrospective study to evaluate the association between the wording of radiologist recommendations for chest CT with the likelihood of recommendation adherence and the diagnostic yield of the recommended follow-up CT imaging.

The researchers looked at 29,138 outpatient chest X-ray studies performed at a tertiary care academic medical center in 2008, to identify examinations that had conditional or absolute recommendations for chest CT.

The findings showed that chest CTs were recommended for 1,316 (4.5%) of outpatient chest X-ray studies. A total of 519 (39.4%) were conditional recommendations and 797 (60.6%) were absolute recommendations. ”Patients with absolute recommendations were significantly more likely to undergo follow-up chest CT within 90 days than patients with conditional recommendations (67.8% versus 45.8%, respectively,” wrote the researchers.

While absolute recommendations did result in more tests, the researchers did not find a significant difference between the conditional and absolute recommendation groups with regard to the incidence of clinically relevant corresponding findings or on follow-up CT.

Related Videos
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Nina Kottler, MD, MS
The Executive Order on AI: Promising Development for Radiology or ‘HIPAA for AI’?
Practical Insights on CT and MRI Neuroimaging and Reporting for Stroke Patients
Related Content
© 2024 MJH Life Sciences

All rights reserved.